• Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial 

      Pascual, T.; Villacampa Javierre, Guillermo; Oliveira, Mafalda; Escrivá-de-Romaní, S.; Pernas, S.; Paré, L.; Adamo, Barbara; Cortés, J.; Perelló, A.; Galán, M.; Melé, Mireia; Villanueva, L.; González-Rodríguez, Marta; Tolosa, Pablo; Gonzalez-Farre, Blanca; Galván, Patricia; Canes, Jordi; Nuciforo, Paolo; Ferrero-Cafiero, Juan Manuel; Gonzàlez Farré, Xavier; Villagrasa-Gonzalez, Patricia; Prat, Aleix; Ciruelos, Eva (ESMO Open, 2025-09-01)
      Background: The SOLTI-1303-PATRICIA trial (NCT02448420) is a phase II study investigating palbociclib and trastuzumab, with or without endocrine therapy, in hormone receptor (HR)-positive/human epidermal ...